Signal from the log
Retham Technologies
1,5 M$ · Seed
Retham Technologies développe HITDx, un test de la thrombopénie induite par l'héparine, une complication rare et grave d'un anticoagulant très utilisé. Le communiqué annonce une première clôture d'amorçage de 1,5 million de dollars. Aucun fonds n'est nommé dans les sources accessibles, l'opération reste donc en réserve.
Spotted
Announced on , logged by the watch of 15 September 2026.
- Operation
- Funding round
- Announced amount
- 1,5 M$
- Stage
- Seed
What the log says
Editorial note, in French
Repérée par la collecte. Personne ne l'a encore instruite.
What is missing before publishing
- No fund is publicly named. It is the first condition of the selection bar: without a named investor there is no round to tell.
Provenance
Source businesswire
Logged on 15 September 2026
Description Written in French during the watch run. Based on the headline as relayed by the source, without reading the issuer's press release.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Spotted The collection saw this operation and logged it. Nobody has processed it yet, so what is shown is still an automatic reading of the source headline.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.